Intrathecal amikacin for the treatment of pseudomonal meningitis

Annals of Pharmacotherapy

Volumn 38, Issue 6, 2004, Pages 992-995

  Corpus, Kimberly A ^a   Weber, Kathryn B ^a   Zimmerman, Christopher R ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Amikacin; Intrathecal administration; Meningitis; Neurosurgery; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; MEROPENEM;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MENINGITIS; CANDIDA GLABRATA; CASE REPORT; CAUSE OF DEATH; CEREBROSPINAL FLUID CULTURE; DEVICE; DISEASE SEVERITY; FEMALE; FUNGEMIA; HUMAN; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SIDE EFFECT; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; AMIKACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SPINAL; MENINGITIS, BACTERIAL; PSEUDOMONAS AERUGINOSA; THIENAMYCINS;

EID: 2442660718     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D541     Document Type: Article

References (20)

1. Buckwold FJ, Hand R, Hansebout RR. Hospital-acquired bacterial meningitis in neurosurgical patients. J Neurosurg 1977;46:494-500.
2. Reichert MCF, Medeiros EAS, Ferraz FAP. Hospital-acquired meningitis in patients undergoing craniotomy: incidence, evolution, and risk factors. Am J Infect Control 2002;30:158-64.
3. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections: 1992; a modification of CDC definitions of surgical wound infections. Am J Infect Control 1992;20:271-4.
4. Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. N Engl J Med 1997;336:708-16.
5. Kralinsky K, Svetlansky I, Kovacicova G, Filka J, Huttova M, Krcmery V Jr. Nosocomial meningitis due to Pseudomonas aeruginosa in children (letter). J Chemother 2000;12:538-9.
6. Mombelli G, Klastersky J, Coppens L, Daneau D, Nubourgh Y. Gram-negative bacillary meningitis in neurosurgical patients. J Neurosurg 1983;58:634-41.
7. McGee ZA, Baringer JR. Acute meningitis. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practices of infectious diseases. 3rd ed. New York: Churchill Livingstone, 1990:741-55.
8. Preston SL, Briceland LL. Intrathecal administration of amikacin for treatment of meningitis secondary to cephalosporin-resistant Escherichia coli. Ann Pharmacother 1993;27:870-3.
9. Wirt TC, McGee ZA, Oldfield EH, Meacham WF. Intraventricular administration of amikacin for complicated gram-negative meningitis and ventriculitis. J Neurosurg 1979;50:95-9.
10. Gilbert VE, Beals JD, Natelson S, Tyler WA. Treatment of cerebrospinal fluid leaks and gram-negative bacillary meningitis with large doses of intrathecal amikacin and systemic antibiotics. Neurosurgery 1986;18:402-6.
11. Hemphill JC III, Beal MF, Gress DR. Critical care neurology. In: Braunwald E, Fauci AS, Isselbacher KJ, Kasper DL, Hauser SL, Longo DL, et al., eds. New York: Harrison's Online; 2001. http://harrisons.accessmedicine.com/harrisons/public/index.html (accessed 2003 Dec 12).
12. Peterson ML, Hoang AD, Wright DH, Rotschafer JC. Central nervous system infections. In: Diprio JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: a pathophysiologic approach. 4th ed. Stamford, CT: Appleton and Lange, 1999:1634-50.
13. Nguyen MH, Harris SP, Muder RR, Pasculle AW. Antibiotic-resistant Acinetobacter meningitis in neurosurgical patients. Neurosurgery 1994;35:851-5.
14. Bray DA, Calcaterra TC. Pseudomonas meningitis complicating head and neck surgery. Laryngoscope 1976;86:1386-90.
15. Kaiser AB, McGee ZA. Aminoglycoside therapy of gram-negative bacillary meningitis. N Engl J Med 1975;293:1215-20.
16. Esen S, Leblebcioglu H, Sunbul M, Eroglu C. Repeated relapses in a meropenem-treated Pseudomonas aeruginosa meningitis (letter). J Chemother 2002;14:535-6.
17. Barriere SL, Conte JE Jr. Case report: emergence of multiple antibiotic resistance during the therapy of Klebsiella pneumoniae meningitis. Am J Med Sci 1980;279:61-5.
18. Karlowsky JA, Draghi DC, Jones ME, Thornsbury C, Friedland IR, Sahm DF. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother 2003;47:1681-8.
19. Hamory B, Ignatiadis P, Sande MA. Intrathecal amikacin administration. JAMA 1976;236:1973-4.
20. Swartz MN. Bacterial meningitis. In: Goldman L, Bennett JC, eds. Cecil textbook of medicine. 21st ed. Philadelphia: WB Saunders, 2000:1645-54.